AKESOgen Triples Its Peachtree Corners, Georgia, Office-Research Campus
01/03/2014
“Since our inception just over three years ago, we have been impressed with the resources, support, and growth opportunities available to biotech companies in Gwinnett County, metro Atlanta and Georgia,” stated Dr. Mark Bouzyk, Chief Scientific Officer for AKESOgen, Inc. “This larger facility will both strengthen our ability to deliver genomics research and development, as well as complement our existing competence in the biotech field.”
“Innovative life science companies such as AKESOgen are what make our state the healthcare hub of the Southeast,” said Carol Henderson, director of life sciences and technology at the Georgia Department of Economic Development. “AKESOgen will lay the foundation for tomorrow’s life science discovery, and we are confident that Georgia’s pro-business climate can support the company in doing so.”
“Our goal as a region is to broaden and enhance life science and technology in the region and an expansion such as this one demonstrates the success of those efforts,” commented Nick Masino, Chair of Georgia’s Innovation Crescent and Senior Vice President of Gwinnett Chamber Economic Development and Partnership Gwinnett. “As a member of the Innovation Crescent Regional Partnership, Gwinnett Chamber Economic Development actively works to promote, support and encourage the growth of companies in these industries.”
“We welcome AKESOgen, and view its investment in the City of Peachtree Corners and Gwinnett as a testament to our community’s strength in this developing, vibrant and progressive industry,” said City of Peachtree Corners Mayor Mike Mason.
Most Read
-
-
The Future of the Workforce Is a “Better Normal”
Workforce Q4 2020
-
Trends in Office and Industrial Parks
Q4 2020
-
Recruiting and Retaining Today’s Manufacturing Workforce
Workforce Q4 2020
-
Another Look at Rural Economies
Q4 2020
-
Supply Chain Execs Respond as Pandemic Creates E-Commerce Surge
Q4 2020
-
Cold Storage Is Hotter Than Ever
Q4 2020